Insights
Professional
Practice
Industry
Region
Trending Topics
Location
Type
Sort by:
Firm News 1 result
Firm News | 11.28.23
Washington – November 28, 2023: In recent years, rapid developments in digital health technologies has made it easier to collect, transfer, and store
electronic data and has expanded the methods in which clinical trial sponsors may conduct research investigations, including through decentralized and
hybrid clinical trials.
electronic data and has expanded the methods in which clinical trial sponsors may conduct research investigations, including through decentralized and
hybrid clinical trials.
Client Alerts 18 results
Client Alert | 12 min read | 04.03.25
CMS Issues Marketplace Integrity and Affordability Proposed Rule
In its first healthcare proposed regulation, the Trump Administration, through the Centers for Medicare & Medicaid Services (CMS), displayed on March 10,
2025, a proposed rule titled, “2025 Marketplace Integrity and Affordability Proposed Rule” (the Proposed Rule), which proposes policy changes for the Health
Insurance Marketplaces that impact health plans and insurers offering Affordable Care Act (ACA) coverage to consumers. Specifically, the Proposed Rule sh...
2025, a proposed rule titled, “2025 Marketplace Integrity and Affordability Proposed Rule” (the Proposed Rule), which proposes policy changes for the Health
Insurance Marketplaces that impact health plans and insurers offering Affordable Care Act (ACA) coverage to consumers. Specifically, the Proposed Rule sh...
Client Alert | 23 min read | 10.31.24
Digital health companies, investors, and other healthcare organizations should follow policy developments with a strategic lens towards their market
opportunities for key potential growth and risk mitigation. On a quarterly basis, we provide relevant legislative and regulatory updates on artificial intelligence
(AI) and digital health policy developments.
opportunities for key potential growth and risk mitigation. On a quarterly basis, we provide relevant legislative and regulatory updates on artificial intelligence
(AI) and digital health policy developments.
Client Alert | 4 min read | 07.29.24
On Monday, July 15, New Jersey Attorney General Matthew J. Platkin and the New Jersey Division of Consumer Affairs released proposed rules (the “Proposed
Rules”) which require certain New Jersey healthcare providers (i.e., physician assistants, physicians, nurses, and midwives) who provide perinatal treatment
and care to pregnant persons to undergo bias training. The training is designed to root out prejudices and stereotypes that may negatively impact the qualit...
Rules”) which require certain New Jersey healthcare providers (i.e., physician assistants, physicians, nurses, and midwives) who provide perinatal treatment
and care to pregnant persons to undergo bias training. The training is designed to root out prejudices and stereotypes that may negatively impact the qualit...
Publications 2 results
Publication | 01.29.24
Westlaw TodayPublication | 11.28.23
Crowell Health SolutionsBlog Posts 30 results
Blog Post | 01.31.25
House Task Force on AI Issues Report and Proposes Healthcare Recommendations
Crowell Health Solution’s Trends in TransformationBlog Post | 01.15.25
AMA’s CPT Editorial Panel Approves New Codes Covering Remote Patient Monitoring Services
Crowell Health Solution’s Trends in TransformationBlog Post | 11.26.24
RCE Issues Technical Guidance Governing TEFCA Exchange
Crowell Health Solution’s Trends in TransformationPodcasts 1 result
Podcast | 02.23.24
In this episode, hosts Payal Nanavati, Jodi Daniel, and Cara Tenenbaum talk to Ben Moscovitch, Devon Adams, and Noah Goodson about recent policy
developments on decentralized clinical trials (DCTs). They also discuss the Crowell Health Solutions’ white paper on DCTs, which issues to federal agencies a
number of policy recommendations to advance DCT adoption and increase clinical trial diversity.
developments on decentralized clinical trials (DCTs). They also discuss the Crowell Health Solutions’ white paper on DCTs, which issues to federal agencies a
number of policy recommendations to advance DCT adoption and increase clinical trial diversity.
